+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Genome Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5925226
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genome testing market presents dynamic growth opportunities for senior decision-makers, with industry transformation shaped by advancing technology, new applications, and evolving regulations. Strategic analysis of this sector is critical for organizations seeking to strengthen their competitive positioning, capture future demand, and respond swiftly to changing market conditions.

Market Snapshot: Genome Testing Market Size & Growth

The genome testing market is forecast to expand from USD 22.45 billion in 2025 to USD 25.51 billion in 2026, with projections reaching USD 55.23 billion by 2032 and a CAGR of 13.72%. Market momentum is propelled by higher demand in clinical diagnostics, accelerated adoption of new sequencing techniques, and ongoing evolution in reimbursement.

Scope & Segmentation

  • Product Types: Includes instruments, kits, reagents and consumables, software, and services. Examples range from microarray scanners and PCR machines to complete analysis platforms, addressing analytical precision and operational throughput.
  • Technology: Covers microarray, next-generation sequencing, PCR, and Sanger sequencing methods. Sub-areas such as expression arrays, digital PCR, and qPCR are driving value for diverse laboratory applications, with advancements from sector leaders such as Illumina and Ion Torrent.
  • Applications: Encompasses hereditary disease testing, infectious disease diagnostics, oncology, pharmacogenomics, and prenatal testing. Specialized focus areas include carrier screening, rare disease profiling, liquid biopsy, and tumor analysis to support both research and clinical needs.
  • End Users: Includes academic institutes, biotech and pharmaceutical companies, diagnostic laboratories, direct-to-consumer providers, hospitals, and clinics. Academic centers, independent laboratories, and online retail clinics characterize the diverse operating environments in this sector.
  • Services: Covers consumer-oriented offerings such as ancestry and wellness analysis, diagnostic services for patient care, and research support for clinical and preclinical studies. Emphasis remains on privacy, regulatory compliance, and scientific validity.
  • Regions: Americas, Europe Middle East & Africa, and Asia-Pacific, each with distinct adoption trajectories, investment profiles, and regulatory environments, shaping unique market entry and scaling strategies.

Key Takeaways: Strategic Insights for Stakeholders

  • Integrated genomic platforms are simplifying laboratory operations and supporting enterprise-level scalability by merging equipment, consumables, and analytics into unified, efficient solutions.
  • Software-delivered services, including sequencing-as-a-service and managed analytics, are gaining favor as healthcare providers aim to enhance operational efficiency while securing predictable service outcomes in clinical use.
  • Prioritizing interoperability and evidence-backed approaches, along with building local manufacturing capabilities, helps organizations remain adaptable amid evolving regulatory and market shocks.
  • New entrants often find success through focused assay chemistries or niche clinical offerings; in contrast, established firms strengthen competitiveness through broad portfolio integration and consistent revenue streams.
  • Regional differences in regulatory policies, payer expectations, and clinical infrastructure require organizations to continuously adapt commercialization and partnership strategies for each major segment and geography.

Tariff Impact: Procurement & Supply Chain Adjustments

The 2025 tariff policies created substantial shifts in procurement and supply chain for genome testing companies. Organizations responded through:

  • Diversification of supplier relationships and alternatives to secure critical inputs and limit disruptions.
  • Expansion of localized inventories and development of domestic distributor partnerships to improve supply chain resilience.
  • Regionalized production choices and enhanced focus on high-margin software or analytics offerings that are less exposed to trade barriers.
  • Redirecting capital investment from equipment acquisition to cloud-enabled analytics and sequencing services to control spending while maintaining capacity.

Methodology & Data Sources

This report adopts a structured mixed-methods approach, combining direct interviews with laboratory and clinical leaders, product managers, and analysis of peer-reviewed literature and regulatory filings. Data integrity is strengthened through cross-verification of industry metrics and adherence to confidentiality standards.

Why This Report Matters: Actionable Outcomes for Leaders

  • Informs alignment of product development and R&D investments with key clinical and regulatory trends for maximum impact.
  • Delivers actionable intelligence on integrating leading genome testing technologies and navigating varying regional landscapes.
  • Supports strategic planning to build agility across procurement, supply chain, and commercialization models in response to market disruptions.

Conclusion

Success in the genome testing market depends on robust technology integration, regulatory awareness, and a data-driven approach to commercialization. Strategic alignment in these dimensions helps secure sustained business advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Genome Testing Market, by Product Type
8.1. Instruments
8.1.1. Microarray Scanners
8.1.2. PCR Machines
8.1.3. Sequencers
8.2. Kits
8.2.1. Exome Kits
8.2.2. Targeted Gene Kits
8.2.3. Whole Genome Kits
8.3. Reagents & Consumables
8.4. Software & Services
8.4.1. Analysis Services
8.4.2. Data Storage Software
8.4.3. Sequencing Services
9. Genome Testing Market, by Technology
9.1. Microarray
9.1.1. Expression Arrays
9.1.2. SNP Arrays
9.2. Next Generation Sequencing
9.2.1. Illumina
9.2.2. Ion Torrent
9.3. PCR
9.3.1. Digital PCR
9.3.2. qPCR
9.4. Sanger Sequencing
10. Genome Testing Market, by Service Type
10.1. Consumer
10.1.1. Ancestry
10.1.2. Lifestyle & Wellness
10.1.2.1. Fitness
10.1.2.2. Nutrition
10.2. Diagnostic
10.2.1. Clinical Diagnostics
10.2.2. Companion Diagnostics
10.3. Research
10.3.1. Clinical Research
10.3.2. Preclinical Research
11. Genome Testing Market, by Application
11.1. Hereditary Disease Testing
11.1.1. Carrier Screening
11.1.2. Rare Disease
11.2. Infectious Disease Testing
11.2.1. Bacterial Detection
11.2.2. Viral Detection
11.3. Oncology Testing
11.3.1. Liquid Biopsy
11.3.2. Solid Tumor Profiling
11.4. Pharmacogenomics
11.5. Prenatal Testing
12. Genome Testing Market, by End User
12.1. Academic Institutes
12.1.1. Research Centers
12.1.2. Universities
12.2. Biotech & Pharma Companies
12.2.1. Biotech Companies
12.2.2. Pharma Companies
12.3. Diagnostic Laboratories
12.3.1. Hospital Labs
12.3.2. Independent Labs
12.4. Direct To Consumer
12.4.1. Online Providers
12.4.2. Retail Clinics
12.5. Hospitals & Clinics
12.5.1. Large Hospitals
12.5.2. Specialized Clinics
13. Genome Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Genome Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Genome Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Genome Testing Market
17. China Genome Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 10x Genomics
18.6. 23andMe, Inc
18.7. Abbott Laboratories
18.8. Agilent Technologies, Inc.
18.9. BGI Group
18.10. Bio-Rad Laboratories, Inc.
18.11. Danaher Corporation
18.12. Eurofins Scientific SE
18.13. F. Hoffmann-La Roche, Ltd.
18.14. Freenome Holdings, Inc.
18.15. GeneDx, LLC
18.16. Genomic Testing Cooperative
18.17. Helix OpCo, LLC
18.18. Illumina, Inc.
18.19. Merck KGaA
18.20. New England Biolabs, Inc.
18.21. Novogene Co, Ltd.
18.22. Oxford Nanopore Technologies PLC
18.23. PerkinElmer Inc.
18.24. QIAGEN N.V.
18.25. Quest Diagnostics Incorporated
18.26. Takara Bio Inc
18.27. Thermo Fisher Scientific Inc.
18.28. Ultima Genomics, Inc.
18.29. VWR International, LLC
List of Figures
FIGURE 1. GLOBAL GENOME TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENOME TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENOME TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENOME TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENOME TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL GENOME TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES GENOME TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA GENOME TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENOME TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENOME TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENOME TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENOME TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENOME TESTING MARKET SIZE, BY PCR MACHINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENOME TESTING MARKET SIZE, BY PCR MACHINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENOME TESTING MARKET SIZE, BY PCR MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENOME TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENOME TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENOME TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENOME TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENOME TESTING MARKET SIZE, BY EXOME KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENOME TESTING MARKET SIZE, BY EXOME KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENOME TESTING MARKET SIZE, BY EXOME KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED GENE KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED GENE KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED GENE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENOME TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENOME TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENOME TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENOME TESTING MARKET SIZE, BY ANALYSIS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENOME TESTING MARKET SIZE, BY ANALYSIS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENOME TESTING MARKET SIZE, BY ANALYSIS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENOME TESTING MARKET SIZE, BY DATA STORAGE SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENOME TESTING MARKET SIZE, BY DATA STORAGE SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENOME TESTING MARKET SIZE, BY DATA STORAGE SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENOME TESTING MARKET SIZE, BY SEQUENCING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENOME TESTING MARKET SIZE, BY EXPRESSION ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENOME TESTING MARKET SIZE, BY EXPRESSION ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENOME TESTING MARKET SIZE, BY EXPRESSION ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENOME TESTING MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENOME TESTING MARKET SIZE, BY SNP ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENOME TESTING MARKET SIZE, BY SNP ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENOME TESTING MARKET SIZE, BY ILLUMINA, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENOME TESTING MARKET SIZE, BY ILLUMINA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENOME TESTING MARKET SIZE, BY ILLUMINA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENOME TESTING MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENOME TESTING MARKET SIZE, BY ION TORRENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENOME TESTING MARKET SIZE, BY ION TORRENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENOME TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENOME TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENOME TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENOME TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENOME TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENOME TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENOME TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENOME TESTING MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENOME TESTING MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENOME TESTING MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENOME TESTING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENOME TESTING MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENOME TESTING MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENOME TESTING MARKET SIZE, BY ANCESTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENOME TESTING MARKET SIZE, BY ANCESTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENOME TESTING MARKET SIZE, BY ANCESTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENOME TESTING MARKET SIZE, BY FITNESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENOME TESTING MARKET SIZE, BY FITNESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENOME TESTING MARKET SIZE, BY FITNESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENOME TESTING MARKET SIZE, BY NUTRITION, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENOME TESTING MARKET SIZE, BY NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENOME TESTING MARKET SIZE, BY NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GENOME TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GENOME TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GENOME TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GENOME TESTING MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GENOME TESTING MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GENOME TESTING MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GENOME TESTING MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENOME TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENOME TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GENOME TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GENOME TESTING MARKET SIZE, BY RARE DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL GENOME TESTING MARKET SIZE, BY RARE DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL GENOME TESTING MARKET SIZE, BY RARE DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL GENOME TESTING MARKET SIZE, BY BACTERIAL DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL GENOME TESTING MARKET SIZE, BY BACTERIAL DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL GENOME TESTING MARKET SIZE, BY BACTERIAL DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL GENOME TESTING MARKET SIZE, BY VIRAL DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL GENOME TESTING MARKET SIZE, BY VIRAL DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL GENOME TESTING MARKET SIZE, BY VIRAL DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL GENOME TESTING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL GENOME TESTING MARKET SIZE, BY LIQUID BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL GENOME TESTING MARKET SIZE, BY LIQUID BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL GENOME TESTING MARKET SIZE, BY SOLID TUMOR PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL GENOME TESTING MARKET SIZE, BY SOLID TUMOR PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL GENOME TESTING MARKET SIZE, BY SOLID TUMOR PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL GENOME TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL GENOME TESTING MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL GENOME TESTING MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL GENOME TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL GENOME TESTING MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL GENOME TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL GENOME TESTING MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL GENOME TESTING MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL GENOME TESTING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMA COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMA COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL GENOME TESTING MARKET SIZE, BY PHARMA COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL GENOME TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL GENOME TESTING MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL GENOME TESTING MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL GENOME TESTING MARKET SIZE, BY RETAIL CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL GENOME TESTING MARKET SIZE, BY RETAIL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL GENOME TESTING MARKET SIZE, BY RETAIL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL GENOME TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL GENOME TESTING MARKET SIZE, BY LARGE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL GENOME TESTING MARKET SIZE, BY LARGE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL GENOME TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL GENOME TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL GENOME TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS GENOME TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS GENOME TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS GENOME TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 222. AMERICAS GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 223. AMERICAS GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
TABLE 224. AMERICAS GENOME TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. AMERICAS GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
TABLE 226. AMERICAS GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2032 (USD MILLION)
TABLE 227. AMERICAS GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 228. AMERICAS GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2032 (USD MILLION)
TABLE 229. AMERICAS GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA GENOME TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA GENOME TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
TABLE 248. NORTH AMERICA GENOME TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. NORTH AMERICA GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2032 (USD MILLION)
TABLE 251. NORTH AMERICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 252. NORTH AMERICA GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2032 (USD MILLION)
TABLE 253. NORTH AMERICA GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA GENOME TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA GENOME TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 271. LATIN AMERICA GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
TABLE 272. LATIN AMERICA GENOME TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. LATIN AMERICA GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
TABLE 274. LATIN AMERICA GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2032 (USD MILLION)
TABLE 275. LATIN AMERICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 276. LATIN AMERICA GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2032 (USD MILLION)
TABLE 277. LATIN AMERICA GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2032 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2032 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2032 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 302. EUROPE GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 303. EUROPE GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 304. EUROPE GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 305. EUROPE GENOME TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 306. EUROPE GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 307. EUROPE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 308. EUROPE GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 309. EUROPE GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 310. EUROPE GENOME TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 311. EUROPE GENOME TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 312. EUROPE GENOME TESTING MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 313. EUROPE GENOME TESTING MARKET SIZE, BY LIFESTYLE & WELLNESS, 2018-2032 (USD MILLION)
TABLE 314. EUROPE GENOME TESTING MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 315. EUROPE GENOME TESTING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 316. EUROPE GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 317. EUROPE GENOME TESTING MARKET SIZE, BY HEREDITARY DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 318. EUROPE GENOME TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 319. EUROPE GENOME TESTING MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
TABLE 320. EUROPE GENOME TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. EUROPE GENOME TESTING MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
TABLE 322. EUROPE GENOME TESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, 2018-2032 (USD MILLION)
TABLE 323. EUROPE GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 324. EUROPE GENOME TESTING MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2032 (USD MILLION)
TABLE 325. EUROPE GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 326. MIDDLE EAST GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 327. MIDDLE EAST GENOME TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 328. MIDDLE EAST GENOME TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 329. MIDDLE EAST GENOME TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 330. MIDDLE EAST GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 331. MIDDLE EAST GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 332. MIDDLE EAST GENOME TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 333. MIDDLE EAST GENOME TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLIO

Companies Mentioned

The key companies profiled in this Genome Testing market report include:
  • 10x Genomics
  • 23andMe, Inc
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche, Ltd.
  • Freenome Holdings, Inc.
  • GeneDx, LLC
  • Genomic Testing Cooperative
  • Helix OpCo, LLC
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Novogene Co, Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc.
  • Ultima Genomics, Inc.
  • VWR International, LLC

Table Information